RF49 Gsk.cap.b.v.32

Publication of GSK Capital BV's 

Annual Report & Financial Statements 2023 

Today, 3 June 2024, GSK Capital B.V. (the "Company") published on the GSK Group ("GSK") website, www.gsk.com*, its Annual Report and Financial Statements in respect of the year ended 31 December 2023. 

In compliance with Listing Rule 9.6.1 of the UK Financial Conduct Authority ("FCA"), copies of the Company's 2023 Annual Report and Financial Statements, have been submitted to the FCA's National Storage Mechanism (NSM) submission portal via Electronic Submission System (ESS). The Company is using the exemption available to it under the Disclosure and Transparency Rules 6.3.5(1A) and is not setting out the full text of the regulated information in this announcement and has instead made the regulated information available in unedited full text on the NSM.

A copy can be viewed at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

V A Whyte 

GSK plc Company Secretary 

3 June 2024

 * https://www.gsk.com/en-gb/company/codes-standards-and-reports/#gsk-capital-plc-annual-reports

Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D "Risk factors" in GSK's Annual Report on Form 20-F for 2023, and GSK's Q1 Results for 2024.